Zobrazeno 1 - 10
of 345
pro vyhledávání: '"M. Brodanová"'
Publikováno v:
European Journal of Clinical Pharmacology. 42:337-340
The disposition kinetics and heart rate reducing effect of deacetylmetipranolol (DMP), the active form of the beta-adrenoreceptor blocking agent metipranolol (MP), administered as a single 40 mg oral dose have been compared in 6 patients with cirrhos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d6c55d28361591bfcf6f259fd1a3e9
https://doi.org/10.1007/bf00266359
https://doi.org/10.1007/bf00266359
Publikováno v:
Vnitrni lekarstvi. 46(7)
Hepatic cysts are at the present time of widespread use of abdominal ultrasonography a frequent finding. The authors summarize contemporary diagnostic possibilities of liver cysts and submit variants of the therapeutic procedure in case of symptomati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fdcf46f0302e3730f3f4b722dc02f1f5
https://pubmed.ncbi.nlm.nih.gov/15635800
https://pubmed.ncbi.nlm.nih.gov/15635800
Autor:
M, Brodanová
Publikováno v:
Vnitrni lekarstvi. 49(8)
Cholestasis is a condition, where the bile flow into the intestine is defective. The causes may be extrahepatic (in large biliary ducts) or intrahepatic (at the level of hepatocytes or minor biliary ducts). The lack of bile in the intestine results i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::acb007f10e50d6d73995a0c0e73b853e
https://pubmed.ncbi.nlm.nih.gov/14518097
https://pubmed.ncbi.nlm.nih.gov/14518097
Autor:
M, Brodanová, F, Perlík
Publikováno v:
Casopis lekaru ceskych. 136(7)
Pharmacotherapy of primary biliary cirrhosis (PBC) was not resolved unequivocally so far. During the last decade bile acids are used more widely. The objective of the submitted paper was to investigate under conditions of an open perspective study th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::622d8385206be0bffee61466057dce57
https://pubmed.ncbi.nlm.nih.gov/9221197
https://pubmed.ncbi.nlm.nih.gov/9221197
Autor:
M, Brodanová
Publikováno v:
Vnitrni lekarstvi. 43(3)
Hepatocellular carcinoma (HCC) is a highly malignant tumour with a poor prognosis. Its incidence is rising. The estimate incidence worldwide is 1 million cases. Most frequently it develops in livers already affected by cirrhotic transformation. How c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e0cefe01abf20a7e4654fb7226e18bd
https://pubmed.ncbi.nlm.nih.gov/9221576
https://pubmed.ncbi.nlm.nih.gov/9221576
Autor:
M, Brodanová
Publikováno v:
Vnitrni lekarstvi. 42(10)
Portal hypertension is a condition with a permanently raised pressure in the portal area. The most frequent cause is restricted blood flow through some part of the circulation. Depending on the site of obstruction, we classify portal hypertension int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0cb067e72327484d83d503df483c7b13
https://pubmed.ncbi.nlm.nih.gov/8975461
https://pubmed.ncbi.nlm.nih.gov/8975461
Autor:
M, Brodanová
Publikováno v:
Casopis lekaru ceskych. 135(17)
The liver is the metabolic centre of all nutrients. Liver disease can thus interfere with the metabolism of the whole organism, it can have a negative impact on the nutritional status and frequently lead to marked malnutrition. On the other hand, att
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::752f58a048c5ce0a4d3d622201416949
https://pubmed.ncbi.nlm.nih.gov/8964073
https://pubmed.ncbi.nlm.nih.gov/8964073
Publikováno v:
Casopis lekaru ceskych. 135(4)
Crigler-Najjar syndrome is a rare disease due to a congenital deficiency of bilirubin UDP glucuronosyl transferase in the liver tissue. It is characterised by high levels of unconjugated bilirubin in plasma through the whole life. The aim of the stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::067ef6c70305db49aad18b048b1938f1
https://pubmed.ncbi.nlm.nih.gov/8625381
https://pubmed.ncbi.nlm.nih.gov/8625381
Publikováno v:
Casopis lekaru ceskych. 135(4)
interferon alpha is nowadays the drug of choice in the treatment of chronic viral hepatitis. The objective of the present work was to assess the effectiveness of interferon alpha in the treatment of chronic active hepatitis B in our population and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c28769e6aebea3e435989eaf18f3af6
https://pubmed.ncbi.nlm.nih.gov/8625380
https://pubmed.ncbi.nlm.nih.gov/8625380
Autor:
M, Brodanová
Publikováno v:
Vnitrni lekarstvi. 42(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06816110874e9bd6e1e4d123751ca8ec
https://pubmed.ncbi.nlm.nih.gov/8686187
https://pubmed.ncbi.nlm.nih.gov/8686187